Nifty 50
- Sun Pharmaceutical₹1,909.4024.40 (1.29%)
- Shriram Finance₹979.30-24.50 (-2.44%)
- Apollo Hospitals₹8,616101.00 (1.19%)
- HDFC Bank₹800.65-11.65 (-1.43%)
- Dr. Reddy's Labs₹1,399.5012.90 (0.93%)
- Titan Company₹4,858-63.90 (-1.30%)
- ONGC₹226.451.95 (0.87%)
- SBI Life Insurance ₹1,797-22.50 (-1.24%)
- HCL Technologies₹1,392.4011.60 (0.84%)
- Mahindra & Mahindra₹3,358.60-40.40 (-1.19%)
- Reliance Industries₹1,347.708.00 (0.60%)
- Bajaj Finserv₹1,865.10-22.00 (-1.17%)
- BSE₹3,92919.90 (0.51%)
- Axis Bank₹1,327.30-15.60 (-1.16%)
- Eicher Motors₹7,58536.00 (0.48%)
- Tata Motors PV₹293.95-3.30 (-1.11%)
- Hindustan Unilever₹1,982.508.50 (0.43%)
- Hindalco Industries₹953.65-10.35 (-1.07%)
- Eternal₹365.501.15 (0.32%)
- Jio Financial ₹228.99-2.21 (-0.96%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Religare Enterprises Reports Net Loss of Rs 98 Cr in Q2
Authored By PTI | Published at: Nov 13, 2026 09:32 AM IST

Open Free Demat Account
New Delhi: Religare Enterprises on Thursday reported a consolidated net loss of Rs 98 crore for the second quarter ended September 2026.
The Burman family-controlled financial services firm had posted a consolidated net profit of Rs 46 crore in the July-September period of the previous fiscal.
Its total income rose to Rs 2,390 crore during the second quarter of the current financial year from Rs 2,089 crore in the year-ago period, Religare Enterprises said in a regulatory filing.
During the quarter, total expenses rose to Rs 2,518 crore against Rs 2,031 crore in the same period a year ago.
Last week, the Reserve Bank of India (RBI) approved the appointment of Anand Burman, Mohit Burman, Aditya Burman and Jimeet Modi to the company’s board.
The company’s subsidiary Religare Finvest resumed lending after the removal of the Corrective Action Plan (CAP) imposed by the RBI.
(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)
Disclaimer
The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.
Open Free Demat Account
₹229.98
By signing up I certify terms, conditions & privacy policy
Join Us
Add as preferred source on Google










